We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

16 hedge funds and large institutions have $57.3M invested in Dare Bioscience in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

55% more capital invested

Capital invested by funds: $37M → $57.3M (+$20.3M)

7% more funds holding

Funds holding: 15 → 16 (+1)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.43%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
2
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
+$2.41M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.8K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$23.1K
4
Principal Financial Group
Principal Financial Group
Iowa
+$7.49K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.99K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$213K
2
BIM
BlackRock Investment Management
Delaware
-$1.25K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$20.4M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.1M – – –
PVMCI
3
Polaris Venture Management Co IV
Massachusetts
$8.94M – – –
RSCM
4
Rock Springs Capital Management
Maryland
$3.42M +$2.41M +3,869 +542%
WSA
5
Wall Street Associates
California
$2.95M – – –
CAM
6
Cormorant Asset Management
Massachusetts
$2.8M – – –
Principal Financial Group
7
Principal Financial Group
Iowa
$1.84M +$7.49K +12 +0.5%
DVC
8
Deer VII & Co
New York
$1.04M – – –
Goldman Sachs
9
Goldman Sachs
New York
$276K – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$186K +$23.1K +37 +17%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$155K +$31.8K +51 +32%
NFC
12
Northeast Financial Consultants
Connecticut
$124K – – –
UBS Group
13
UBS Group
Switzerland
$13K +$10.6K +17 New
BIT
14
BlackRock Institutional Trust
California
$11K – – –
BIM
15
BlackRock Investment Management
Delaware
$10K -$1.25K -2 -13%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$6K +$4.99K +8 New
UOC
17
UBS O'Connor
Illinois
– -$213K -420 Closed

DARE Hedge Fund Activity: Q4 2014 in Review

16 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2014, worth a combined $57.3M — up 55% from $37M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new DARE positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Rock Springs Capital Management, adding an estimated $2.41M. The largest seller was UBS O'Connor, exiting entirely with an estimated $213K sold.

  • 16 institutional investors held Dare Bioscience (DARE) as of Q4 2014, up from 15 in Q3 2014.
  • Funds reported $57.3M of Dare Bioscience stock for Q4 2014, up 55% quarter-over-quarter.
  • 2 funds opened new Dare Bioscience positions in Q4 2014 and 1 closed out, a net change of +1 holder.
  • The largest Dare Bioscience buyer in Q4 2014 was Rock Springs Capital Management, an estimated $2.41M added.
  • The largest Dare Bioscience seller in Q4 2014 was UBS O'Connor, an estimated $213K sold.

Based on aggregated 13F filings for Q4 2014.